NIH-funded research R01 grant

Automated language analysis for Alzheimer's and frontotemporal dementia in Latino and English-speaking communities

Official title: An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populations

Funded at University of California, San Francisco · NIH-11553466 · Data updated 2026-11-12

A low-cost, computer-based language analysis method is being developed to help identify Alzheimer’s disease and frontotemporal dementia in Latino and English-speaking people.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startAugust 15, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$126,773
NIH project number3R01AG075775-04S2
Project IDNIH-11553466 on NIH RePORTER

Who could benefit from this research

Could help

Adults (and older adults) who are Latinos and English speakers, with diagnosed AD, FTD, or no cognitive impairment, across multiple countries and U.S. settings.

Less likely to help

Individuals without cognitive concerns or those outside the target linguistic and cultural groups may not benefit directly.

What this research studies

This project will create a computer-based system that uses speech and language patterns to detect and predict neurodegenerative changes in diverse Latino and English-speaking populations. It will collect natural speech data from thousands of participants, extract acoustic and linguistic features, and apply machine learning to differentiate Alzheimer’s disease from frontotemporal dementia and from healthy aging. The approach emphasizes cultural and socio-biological differences to ensure the tools work well across language and dialect groups. By focusing on scalable, accessible testing, the study aims to improve early and accurate diagnosis where traditional methods are less affordable. The research will be conducted at UC San Francisco with a large, diverse cohort to validate the framework across languages and ethnic backgrounds.

Why it matters

Potential benefit: If successful, the method could enable earlier, more accurate diagnosis of AD and FTD in diverse populations using affordable speech-based tests.

How similar studies have gone: Previous work shows promise for speech-based markers in neurodegenerative diseases, but validation across diverse Latino and English-speaking populations is limited, making this study novel.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Gorno Tempini, Maria Luisa — University of California, San Francisco
  • Study coordinator: Gorno Tempini, Maria Luisa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.